Celmatix
Curated by SignalHarnessing the power of data and genomics to optimize medical decisions about fertility.
Overview
Celmatix focuses on women’s health. It uses predictive analytics and genomics to create products that help in infertility treatment and proactive fertility management. The company offers POLARIS, a cloud- based analytics platform for optimizing a woman’s fertility by calculating the personal likelihood of success using various fertility treatment options, tailored to a patient’s clinical metrics. In addition, the company offers Fertilome, an NGS assay that enables women to evaluate present and future fertility potential. Fertilome analyzes 49 different variants in 32 genes, and is specifically aimed at women who plan to freeze their eggs, have children after the age of 35, or have risk factors that affect fertility such as PCOS, depleted ovarian reserve, endometriosis or other endocrine disorders.
Key facts
- Founded
- 2009
- Headquarters
- New York City, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view